Liver Cirrhosis Recruiting Phase Trials for Rifaximin (DB01220)

Also known as: Cirrhosis, Liver / Cirrhosis / Cirrhosis (of liver) NOS / Cirrhosis of liver / Cirrhosis liver / Hepatic cirrhosis NOS / Hepatic cirrhosis

IndicationStatusPhase
DBCOND0028911 (Liver Cirrhosis)RecruitingNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02964195Efficacy of Rifaximin in Treatment of Cirrhotic Gastroesophageal Variceal BleedingPrevention
NCT02439307Effect of Rifaximin on Minimal Hepatic Encephalopathy and Small Intestinal Bacterial OvergrowthTreatment